Page results
-
UCLH NHS Foundation Trust has once again formed a partnership with the Business Design Centre in Islington to reopen a large-scale COVID-19 vaccination centre on site from Saturday 18 December.
-
University College London Hospitals (UCLH) is now administering new COVID-19 treatments for patients at highest risk in the community.
-
Professor Manjit Matharu's major research interests include migraine, trigeminal autonomic cephalalgias, facial pain, neurostimulation for intractable headaches, spontaneous intracranial hypotension and other headache disorders in hypermobility syndromes.
-
Having proton beam therapy: information for children aged 5-8 patient information page.
-
Having proton beam therapy: information for children aged 9-12 patient information
-
Having proton beam therapy: information for teenagers aged 13-17 patient information.
-
Our vaccination centre at the Business Design Centre, Islington, closed on Monday 10 January.
-
This Mobile Health Clinic has been extensively refurbished and fitted with a new digital portable x-ray camera and modern technologies to speed patient diagnoses and treatment of infectious diseases that will be powered on green energy.
-
The haematology and critical care services in our flagship University College Hospital Grafton Way Building are now open.
-
The Secretary of State for Health and Social Care Sajid Javid came to University College Hospital Grafton Way Building on Friday 4 February 2022.
File results
-
FOI/2023/0145 - Waiting times for consultant-led treatment, inpatient and outpatients
-
FOI/2023/0143 - Immunoassay Analysers at Trust
-
FOI/2023/0142 - Treatment of breast cancer
-
FOI/2023/0139 - Meningitis and Encephalitis guidelines/ pathway
-
FOI/2023/0138 - Subject Access Requests (SARs) and Freedom of Information Requests
-
FOI/2023/0114 - Electronic Patient Record/ Electronic Health Record systems
-
FOI/2023/0117 - EPRR Team contact information
-
FOI/2023/0115 - Deaths in A&E
-
FOI/2023/0119 - Post occupancy evaluations following completion of a capital project
-
FOI/2023/0111 - Migraine treatment